Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae (ESBLE) in a Geriatric Unit: an Interventional Prospective Noninferiority Non-randomized Double-blind Controlled Before and After Study

NCT05475574 is registered in ClinicalTrials.gov with Centre Hospitalier Régional Metz-Thionville as lead sponsor.

NCT NCT05475574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05475574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae (ESBLE) in a Geriatric Unit: an Interventional Prospective Noninferiority Non-randomized Double-blind Controlled Before and After Study
Lead sponsor
Centre Hospitalier Régional Metz-Thionville
Phase
Not applicable
Overall status
Recruiting
Start date
March 7, 2023
Completion date
September 21, 2029
Enrollment
954 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection, hospital